IDEAYA Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	157.52	112.83	84.38	157.02	68.63	92.05
Short-Term Investments	513.68	526.56	591.94	368.1	296.2	154.72
Cash & Short-Term Investments	671.2	639.39	676.32	525.11	364.83	246.77
Cash Growth	-3.08%	-5.46%	28.79%	43.93%	47.84%	-12.98%
Accounts Receivable	-	-	-	0.02	0.21	1.1
Other Current Assets	24.91	27.34	13.39	7.5	5.41	3.12
Total Current Assets	696.11	666.73	689.71	532.63	370.45	251
Net Property, Plant & Equipment	31.25	31.29	27.74	8.41	8.99	8.66
Long-Term Investments	301.71	410.3	405.83	107.49	8.32	121.29
Other Long-Term Assets	1.28	1.02	0.81	0.78	0.21	0.4
Total Assets	1,030	1,109	1,124	649.32	387.97	381.35
Accounts Payable	20.74	17.58	15.42	6.6	4.28	2.1
Accrued Expenses	43.75	40.89	30.35	18.76	17	12.32
Current Portion of Leases	0.35	0.34	0.3	1.75	1.87	1.7
Unearned Revenue	-	-	-	-	8.57	29.04
Total Current Liabilities	64.83	58.82	46.07	27.1	31.72	45.16
Long-Term Leases	28.25	27.58	18.87	1.13	1.61	3.48
Other Long-Term Liabilities	-	-	-	-	5.19	31.19
Total Long-Term Liabilities	28.25	27.58	18.87	1.13	6.8	34.67
Total Liabilities	93.08	86.39	64.94	28.23	38.51	79.83
Common Stock	0.01	0.01	0.01	0.01	0.01	0
Additional Paid-in Capital	1,773	1,757	1,681	968.89	587.72	478.97
Accumulated Other Comprehensive Income	-0.49	2.27	0.81	0.56	-2.87	-0.71
Retained Earnings	-835.08	-736.54	-622.84	-348.36	-235.4	-176.75
Shareholders' Equity	937.27	1,023	1,059	621.09	349.46	301.51
Total Liabilities & Equity	1,030	1,109	1,124	649.32	387.97	381.35
Total Debt	28.6	27.91	19.17	2.87	3.48	5.18
Net Cash (Debt)	642.6	611.47	657.15	522.24	361.35	241.59
Net Cash Growth	5.09%	-6.95%	25.83%	44.53%	49.57%	-12.74%
Net Cash Per Share	7.23	6.91	8.05	9.08	8.72	6.85
Book Value	937.27	1,023	1,059	621.09	349.46	301.51
Book Value Per Share	10.55	11.56	12.97	10.80	8.43	8.55
Tangible Book Value	937.27	1,023	1,059	621.09	349.46	301.51
Tangible Book Value Per Share	10.55	11.56	12.97	10.80	8.43	8.55

Updated May 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q